Management of mild cognitive impairment (MCI): the need for national and international guidelines
These materials are not for human or animal consumption, medical use, diagnostic procedures, therapeutic applications, or veterinary use of any kind
Increased thirst is not officially listed as a direct side effect in FDA prescribing information, but some patients report it anecdotally
Participants also recorded reductions in waist circumference (average 7.1cm loss on 6mg, 8.2cm on 12mg, 10cm on 36mg, compared with 3.1cm loss on placebo), blood pressure (estimated -4.2 and -1mm HG difference between placebo and orforglipron in systolic and diatolic blood pressure, respectively) and cholesterol (-2.1% difference between placebo and orforglipron)
Research-grade material is sold as a research-use-only chemical, so vendors do not ask for a prescription
Thats why we dont just hand you a vial